Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

Abstract

Prostate cancer is the second most common malignancy in men worldwide and consists of a mixture of tumor and non-tumor cell types. To characterize the prostate cancer tumor microenvironment, we perform single-cell RNA-sequencing on prostate biopsies, prostatectomy specimens, and patient-derived organoids from localized prostate cancer patients. We uncover heterogeneous cellular states in prostate epithelial cells marked by high androgen signaling states that are enriched in prostate cancer and identify a population of tumor-associated club cells that may be associated with prostate carcinogenesis. ERG -negative tumor cells, compared to ERG -positive cells, demonstrate shared heterogeneity with surrounding luminal epithelial cells and appear to give rise to common tumor microenvironment responses. Finally, we show that prostate epithelial organoids harbor tumor-associated epithelial cell states and are enriched with distinct cell types and states from their parent tissues. Our results provide diagnostically relevant insights and advance our understanding of the cellular states associated with prostate carcinogenesis.

References 103

1. 1.

   Tiwari, R., Manzar, N. & Ateeq, B. Dynamics of cellular plasticity in prostate cancer progression. Front. Mol. Biosci. 7, 130 (2020).

   Not in our library10.3389/fmolb.2020.00130

2. 2.

   Blau HM, et al. Plasticity of the differentiated state. Science. 1985;230:758-766.

   Not in our library10.1126/science.2414846

3. 3.

   Yuan S, Norgard RJ, Stanger BZ. Cellular plasticity in cancer. Cancer Discov. 2019;9:837-851.

   Not in our library10.1158/2159-8290.cd-19-0015

4. 4.

   Varga J, Greten FR. Cell plasticity in epithelial homeostasis and tumorigenesis. Nat. Cell Biol. 2017;19:1133-1141.

   Not in our library10.1038/ncb3611

5. 5.

   Boutros PC, et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 2015;47:736-745.

   Not in our library10.1038/ng.3315

6. 6.

   Cooper CS, et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 2015;47:367-372.

   Not in our library10.1038/ng.3221

7. 7.

   DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet. 2003;361:955-964.

   Not in our library10.1016/s0140-6736(03)12779-1

8. 8.

   Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010;24:1967-2000.

   Not in our library10.1101/gad.1965810

9. 9.

   Henry GH, et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep. 2018;25:3530-3542.e5.

   Not in our library10.1016/j.celrep.2018.11.086

10. 10.

    Tomlins SA, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648.

    Not in our library10.1126/science.1117679

11. 11.

    Bhatia V, Ateeq B. Molecular underpinnings governing genetic complexity of ETS-fusion-negative prostate cancer. Trends Mol. Med. 2019;25:1024-1038.

    Not in our library10.1016/j.molmed.2019.07.001

12. 12.

    Abeshouse A, et al. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011-1025.

    Not in our library10.1016/j.cell.2015.10.025

13. 13.
    Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies · 2020

    No notice
14. 14.

    Tirosh I, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189-196.

    Not in our library10.1126/science.aad0501

15. 15.

    Zilionis R, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50:1317-1334.e10.

    Not in our library10.1016/j.immuni.2019.03.009

16. 16.
    Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases · 2019

    No notice
17. 17.
    Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway · 2018

    No notice
18. 18.

    Hadadi, E. et al. Differential IL-1β secretion by monocyte subsets is regulated by Hsp27 through modulating mRNA stability. Sci. Rep. 6, 1–13 (2016).

    Not in our library10.1038/srep39035

19. 19.

    Aran D, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 2019;20:163-172.

    Not in our library10.1038/s41590-018-0276-y

20. 20.

    Stuart T, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888-1902.e21.

    Not in our library10.1016/j.cell.2019.05.031

21. 21.

    Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 2018;36:411-420.

    Not in our library10.1038/nbt.4096

22. 22.

    Yue X, et al. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Hepatology. 2017;65:1948-1962.

    Not in our library10.1002/hep.29036

23. 23.

    Zhang Q, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699.

    Not in our library10.1038/onc.2016.240

24. 24.

    Fotiou K, et al. Serum ceruloplasmin as a marker in prostate cancer. Minerva Urol. E Nefrol. Ital. J. Urol. Nephrol. 2007;59:407-411.

    Not in our library

25. 25.

    Abeshouse, A. et al. The molecular taxonomy of primary prostate cancer. Cell163, 1011–1025 (2015).

    Not in our library10.1016/j.cell.2015.10.025

26. 26.

    Setlur SR, et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J. Natl Cancer Inst. 2008;100:815-825.

    Not in our library10.1093/jnci/djn150

27. 27.
    Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods · 2019

    No notice
28. 28.

    Qian, X. et al. Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker. PLoS ONE7, e37225 (2012).

    Not in our library10.1371/journal.pone.0037225

29. 29.

    Kenny PA. InferCNV, a python web app for copy number inference from discrete gene-level amplification signals noted in clinical tumor profiling reports. F1000Research. 2019;8:807.

    Not in our library10.12688/f1000research.19541.1

30. 30.

    Ellis L, Loda M. Advanced neuroendocrine prostate tumors regress to stemness. Proc. Natl Acad. Sci. USA. 2015;112:14406-14407.

    Not in our library10.1073/pnas.1519151112

31. 31.

    Goto K, et al. Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells. 2006;24:1859-1868.

    Not in our library10.1634/stemcells.2005-0585

32. 32.

    Tsujimura A, et al. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J. Cell Biol. 2002;157:1257-1265.

    Not in our library10.1083/jcb.200202067

33. 33.
    Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer · 1998

    Not checked
34. 34.

    Montoro DT, et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature. 2018;560:319-324.

    Not in our library10.1038/s41586-018-0393-7

35. 35.

    Thorek DL, Evans MJ, Carlsson SV, Ulmert D, Lilja H. Prostate specific kallikrein-related peptidases and their relation to prostate cancer biology and detection; established relevance and emerging roles. Thromb. Haemost. 2013;110:484-492.

    Not in our library10.1160/th13-04-0275

36. 36.

    Hessels D, Schalken JA. Urinary biomarkers for prostate cancer: a review. Asian J. Androl. 2013;15:333-339.

    Not in our library10.1038/aja.2013.6

37. 37.

    Zhang L, Barritt GJ. TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr. Relat. Cancer. 2006;13:27-38.

    Not in our library10.1677/erc.1.01093

38. 38.

    Smith BA, et al. A human adult stem cell signature marks aggressive variants across epithelial cancers. Cell Rep. 2018;24:3353-3366.e5.

    Not in our library10.1016/j.celrep.2018.08.062

39. 39.

    Guo W, et al. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat. Genet. 2020;52:908-918.

    Not in our library10.1038/s41588-020-0642-1

40. 40.

    Gurioli G, et al. Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. J. Transl. Med. 2016;14:249.

    Not in our library10.1186/s12967-016-1014-6

41. 41.

    Tung M-C, et al. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. Prostate. 2013;73:1281-1290.

    Not in our library10.1002/pros.22670

42. 42.

    Nelson PS, et al. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl Acad. Sci. USA. 2002;99:11890-11895.

    Not in our library10.1073/pnas.182376299

43. 43.
    Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer · 2019

    No notice
44. 44.

    Fujita K, Nonomura N. Role of androgen receptor in prostate cancer: a review. World J. Mens. Health. 2019;37:288-295.

    Not in our library10.5534/wjmh.180040

45. 45.

    Karthaus WR, et al. Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science. 2020;368:497-505.

    Not in our library10.1126/science.aay0267

46. 46.

    Chen S, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 2021;23:87-98.

    Not in our library10.1038/s41556-020-00613-6

47. 47.

    Guérin O, Fischel JL, Ferrero J-M, Bozec A, Milano G. EGFR targeting in hormone-refractory prostate cancer: current appraisal and prospects for treatment. Pharmaceuticals. 2010;3:2238-2247.

    Not in our library10.3390/ph3072238

48. 48.

    Varma M, Berney DM, Jasani B, Rhodes A. Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining. J. Clin. Pathol. 2004;57:687-690.

    Not in our library10.1136/jcp.2003.014894

49. 49.

    Abida W, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl Acad. Sci. USA. 2019;116:11428-11436.

    Not in our library10.1073/pnas.1902651116

50. 50.
    AP-1 Transcription Factors as Regulators of Immune Responses in Cancer · 2019

    No notice
51. 51.
    The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers · 2009

    No notice
52. 52.
    Efficient Test and Visualization of Multi-Set Intersections · 2015

    No notice
53. 53.

    Fay, A. P. & Antonarakis, E. S. Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction? Ann. Transl. Med. 7, (2019).

    Not in our library10.21037/atm.2019.01.37

54. 54.
    Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion · 2018

    No notice
55. 55.
    Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer · 2017

    No notice
56. 56.

    Oh DY, et al. Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell. 2020;181:1612-1625.e13.

    Not in our library10.1016/j.cell.2020.05.017

57. 57.
    Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages · 2019

    Corrected
58. 58.
    Novel Markers to Delineate Murine M1 and M2 Macrophages · 2015

    No notice
59. 59.

    Siefert, J. C. et al. The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics. Mol. Cancer Res.10.1158/1541-7786.MCR-20-0740 (2021).

    Not in our library10.1158/1541-7786.mcr-20-0740

60. 60.

    Azizi E, et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell. 2018;174:1293-1308.e36.

    Not in our library10.1016/j.cell.2018.05.060

61. 61.

    Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep. 2014;6:13.

    Not in our library10.12703/p6-13

62. 62.

    Zhang L, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181:442-459.e29.

    Not in our library10.1016/j.cell.2020.03.048

63. 63.

    Chakarov S, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363:eaau0964.

    Not in our library10.1126/science.aau0964

64. 64.
    Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade · 2017

    No notice
65. 65.

    Youn J-I, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 2010;40:2969-2975.

    Not in our library10.1002/eji.201040895

66. 66.

    Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol. Res. 2017;5:3-8.

    Not in our library10.1158/2326-6066.cir-16-0297

67. 67.

    Calcinotto A, et al. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature. 2018;559:363-369.

    Not in our library10.1038/s41586-018-0266-0

68. 68.
    Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression · 2018

    No notice
69. 69.

    Karthaus WR, et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell. 2014;159:163-175.

    Not in our library10.1016/j.cell.2014.08.017

70. 70.

    Drost J, et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat. Protoc. 2016;11:347-358.

    Not in our library10.1038/nprot.2016.006

71. 71.

    Mani SA, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704-715.

    Not in our library10.1016/j.cell.2008.03.027

72. 72.

    Medeiros Tavares Marques, J. C. et al. Identification of new genes associated to senescent and tumorigenic phenotypes in mesenchymal stem cells. Sci. Rep. 7, 1–13 (2017).

    Not in our library10.1038/s41598-017-16224-5

73. 73.

    Hashimoto, S. et al. Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues. Sci. Rep. 7, 1–14 (2017).

    Not in our library10.1038/s41598-017-14676-3

74. 74.

    McCray T, Moline D, Baumann B, Vander Griend DJ, Nonn L. Single-cell RNA-Seq analysis identifies a putative epithelial stem cell population in human primary prostate cells in monolayer and organoid culture conditions. Am. J. Clin. Exp. Urol. 2019;7:123-138.

    Not in our library

75. 75.

    Fraser M, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017;541:359-364.

    Not in our library10.1038/nature20788

76. 76.

    Barbieri CE, et al. The mutational landscape of prostate cancer. Eur. Urol. 2013;64:567-576.

    Not in our library10.1016/j.eururo.2013.05.029

77. 77.

    Baca SC, et al. Punctuated evolution of prostate cancer genomes. Cell. 2013;153:666-677.

    Not in our library10.1016/j.cell.2013.03.021

78. 78.

    Manyak MJ, Kikukawa T, Mukherjee AB. Expression of a uteroglobin-like protein in human prostate. J. Urol. 1988;140:176-182.

    Not in our library10.1016/s0022-5347(17)41522-9

79. 79.

    Liu X, et al. Low CD38 identifies progenitor-like inflammation-associated luminal cells that can initiate human prostate cancer and predict poor outcome. Cell Rep. 2016;17:2596-2606.

    Not in our library10.1016/j.celrep.2016.11.010

80. 80.

    Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell-of-origin for human prostate cancer. Science. 2010;329:568-571.

    Not in our library10.1126/science.1189992

81. 81.

    Wang X, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009;461:495-500.

    Not in our library10.1038/nature08361

82. 82.

    Krop I, et al. Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol. Cancer Res. MCR. 2004;2:489-494.

    Not in our library

83. 83.
    Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma · 2020

    Corrected
84. 84.

    Marjanovic ND, et al. Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell. 2020;38:229-246.e13.

    Not in our library10.1016/j.ccell.2020.06.012

85. 85.

    Puram SV, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171:1611-1624.e24.

    Not in our library10.1016/j.cell.2017.10.044

86. 86.

    Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat. Rev. Cancer. 2002;2:389-396.

    Not in our library10.1038/nrc801

87. 87.

    Teo MY, Rathkopf DE, Kantoff P. Treatment of advanced prostate cancer. Annu. Rev. Med. 2019;70:479-499.

    Not in our library10.1146/annurev-med-051517-011947

88. 88.

    Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate-resistance and novel therapeutic approaches. Oncogene. 2013;32:5501-5511.

    Not in our library10.1038/onc.2013.206

89. 89.
    Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer · 2020

    Not checked
90. 90.
    Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers · 2018

    No notice
91. 91.
    Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing · 2020

    No notice
92. 92.

    Team, C. Is the playing field level in prostate cancer? Wellcome Sanger Institute Bloghttps://sangerinstitute.blog/2015/04/01/is-the-playing-field-level-in-prostate-cancer/ (2015).

    Not in our library

93. 93.

    Pietrzak K, et al. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss. Proc. Natl Acad. Sci. USA. 2020;117:3637-3647.

    Not in our library10.1073/pnas.1911673117

94. 94.

    Chua CW, et al. Single luminal epithelial progenitors can generate prostate organoids in culture. Nat. Cell Biol. 2014;16:951-954.

    Not in our library10.1038/ncb3047

95. 95.
    Identification of a Master Regulator of Differentiation in Toxoplasma · 2020

    No notice
96. 96.

    Auwera, G. van der & O’Connor, B. D. Genomics in the cloud: using Docker, GATK, and WDL in Terra (O'Reilly Media, 2020).

    Not in our library

97. 97.

    Trivedi, U. H. et al. Quality control of next-generation sequencing data without a reference. Front. Genet. 5, 111 (2014).

    Not in our library10.3389/fgene.2014.00111

98. 98.

    Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.

    Not in our library10.1093/bioinformatics/bts635

99. 99.

    McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329-337.e4.

    Not in our library10.1016/j.cels.2019.03.003

100. 100.

     Koga, Y. et al. Genomic profiling of prostate cancers from men with African and European ancestry. Clin. Cancer Res. 10.1158/1078-0432.CCR-19-4112 (2020).

     Not in our library10.1158/1078-0432.ccr-19-4112

101. 101.

     Huang FW, et al. Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations. Cancer Discov. 2017;7:973-983.

     Not in our library10.1158/2159-8290.cd-16-0960

102. 102.
     Clustering trees: a visualization for evaluating clusterings at multiple resolutions · 2018

     No notice
103. 103.
     SCANPY: large-scale single-cell gene expression data analysis · 2018

     No notice

Cited by papers we hold 4

• Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses · 2023
  No notice
• Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance · 2023
  No notice
• Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease · 2022
  No notice
• Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance · 2022
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.